Conference Coverage

For pediatric use of supplements, rely on resources, evidence


 

EXPERT ANALYSIS FROM AAP 19

NEW ORLEANS – More than 1 in 10 children (12%) have received complementary or alternative medicine (CAM), according to the 2012 National Health Interview Survey. It’s therefore vital that you are familiar with the options and evidence on these treatments, according to Cora Breuner, MD, a professor of pediatrics at the University of Washington, Seattle, and attending physician at Seattle Children’s Hospital.

A serious teenage girl sits at a table across from her physician. Her father sits next to her as she listens to the doctor explain test results displayed on a digital tablet.

“Use of CAM by a parent was strongly associated with the child’s use of CAM,” Dr. Breuner told attendees at the annual meeting of the American Academy of Pediatrics. Parents of children using CAM were more likely to have a college education and to use prescription medication, the National Health Interview Survey found, and teens were more frequent users of CAM than infants.

The most common conditions treated in children with CAM were back and neck pain, colds, anxiety, stress, ADHD, insomnia, and general musculoskeletal conditions or complaints. Fish oil, melatonin, probiotics, and chiropractic and osteopathic manipulation were used more frequently than any other CAM treatments, but Dr. Breuner’s presentation focused specifically on supplements, including vitamins and herbs.

Physicians generally know that regulation of supplements is far less strict than for prescription medication, but patients may be less aware of how lax the law is when it comes to the safety and effectiveness of vitamins, minerals, herbs, and other dietary supplements.

“Products can go on the market with no testing of efficacy, and companies do not have to prove that their products are safe – only offer reasonable assurance of safety,” Dr. Breuner explained. “Supplements do not have to be manufactured to any standards, and FDA [Food and Drug Administration] approval is not needed for package or marketing claims,” although the reputable manufacturers favor standards.

She cited a 2011 study of popular supplement products on the market that found 75% of them did not include key safety messages (BMC Med. 2011 Aug 9;9:94). The study focused on St. John’s wort, ginkgo, ginseng, garlic, and echinacea products, and it’s likely other products lack such safety information as well. Yet researchers have identified a wide range of potential adverse effects from herbal medicines (Clin Med [Lond]. 2013 Feb;13[1]:7-12).

Physicians and consumers can rely on a handful of voluntary standards and online databases to guide therapeutic decisions and learn more about the evidence on specific products. The U.S. Pharmacopeia Dietary Supplement Verification Program is a seal consumers can look for on supplement products that indicates the product meets stricter standards than what the FDA allows.

Dr. Cora C. Breuner, chairperson of the AAP Committee on Adolescence

Dr. Cora C. Breuner

Other resources include ConsumerLab.com, the Natural Medicines Research Collaboration, and the Pubmed Dietary Supplement Subset database from the National Institute of Medicine. The latter contains more than 676,000 unique scientific citations on published studies about vitamins, minerals, and botanicals, Dr. Breuner said.

Dr. Breuner presented an overview of more than a dozen popular supplements that included their uses and the evidence related to their use. Although not exhaustive, her list included the most common supplements for which some research has been done: butterbur, caffeine, cannabidiol, coenzyme Q10, echinacea, magnesium, melatonin, N-acetylcysteine, omega 3 fatty acids, St. John’s wort, turmeric (curcumin), and zinc.

The findings from these studies, however, vary greatly, and the studies themselves are often small and limited to adults. Shared decision making is key in working with families interested in using CAM, and families should be aware that supplements can have side effects just as FDA-approved drugs do.

Dr. Breuner reported that she had no relevant financial disclosures.

Recommended Reading

Women with epilepsy less likely than controls to breastfeed
Clinician Reviews
Head Injuries
Clinician Reviews
Bariatric surgery tied to fewer cerebrovascular events
Clinician Reviews
Pimavanserin reduced dementia-related psychotic symptoms without affecting cognition
Clinician Reviews
FDA committee rejects oxycodegol, new opioid designed for less abuse
Clinician Reviews
FDA advisers set high bar for new opioids
Clinician Reviews
Zika virus: Birth defects rose fourfold in U.S. hardest-hit areas
Clinician Reviews
Modafinil use in pregnancy tied to congenital malformations
Clinician Reviews
Genetic factor linked to impaired memory after heading many soccer balls
Clinician Reviews
Dietary flavonol intake linked to reduced risk of Alzheimer’s
Clinician Reviews